USP Education Webinar on <1058>
Recommendation

Monday, 21 September 2026 14.00 - 16.00 h
Regulatory Landscape: ECHA, USP, Pharmacopoeias and FDA Enforcement
As reported in March, a proposed revision of the existing USP Chapter <1058> Analytical Instrument Qualification has been published for comments in the Pharmacopeial Forum, PF 51(2). The informational chapter provides general guidance in a scientific, risk-based approach for carrying out an analytical instrument and system qualification (AISQ).
In this context, Dr Christopher Burgess, Chairman of the ECA Analytical Quality Control Group (AQCG), and USP GCCA Expert Committee Member, will present a one-hour webinar organized and carried out by USP Education.
This Live Webcast, "Enhancement of General Chapter Analytical Instruments and Systems Qualification; a full lifecycle approach", is scheduled for 10 June 2025.
The topics covered are:
- Rational and Goals of the Revision Proposal
- Support of USP <1220> Analytical Procedures Lifecycle
- “Fitness for Intended Use” of Analytical Instruments and systems
For further information, please see the USP Education website.
Related GMP News
03.09.2026USP Article: Supporting the Detection of Asbestos in Pharmaceutical Talc
02.09.2026USP Publishes Comments Received on Chapter <320>
26.08.2026New USP Requirements for Asbestos Testing in Pharmaceutical Talc
19.08.2026FDA Warning Letter: Averaging Data to Override OOS Findings
12.08.2026ECA's Analytical Control Group Publishes Detailed Report on OOS Survey
12.08.2026BP Publishes Key Insights on Limits in Chromatographic Tests


